Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
YesterdayDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
YesterdayRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
YesterdayThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
YesterdayBuffalo Potash Files Annual Information Form and New Technical Report
YesterdayIonik Announces 30-Day Extension of Senior Debt Facility
Helix Biopharma Corp. logo

Helix Biopharma Corp.

About

1.63CAD+0.03 +1.87%
Closed • Updated at 16:35 GMT+00:00
Market Cap$90.32M
Volume200
Beta3.27
RSI40.91
Health TechnologyPharmaceuticals: Major

Helix Biopharma Corp. — investor relations, events, news, and company updates on 6ix.

Latest News

May 13 2026
Helix Biopharma Corp. Announces Strategic Board and Governance Appointments to Support Financing and Nasdaq Uplisting Strategy
Mar 16 2026
Helix BioPharma Corp. Announces Financial Results and Filing of Interim Financial Statements as of and for the Three- and Six-Month Periods Ended January 31, 2026
Feb 24 2026
Helix BioPharma Corp. Announces Presentation at 16th Annual World ADC London
Feb 5 2026
Helix Biopharma Corp. Extends LEUMUNA Option With metaShape Pharma for Adipose Tissue-Related and Metabolic Diseases
Feb 5 2026
Helix Biopharma Corp. Extends LEUMUNA Option with metaShape Pharma for Adipose Tissue-Related and Metabolic Diseases

Community Chat

Ask AI

Try asking
6ix6ixAIEvents